Paradigm Health, FDA Advance Real-Time Trial Review Model
WASHINGTON & COLUMBUS, OHIO, April 28, 2026 Paradigm Health has announced a landmark research collaboration with the U.S. Food...
drug development
Advertisement
Kestrel Therapeutics Doses First Patient in KRAS Trial
WATERTOWN, MASSACHUSETTS, April 28, 2026 Kestrel Therapeutics Inc. has announced a major clinical milestone with the first patient dosed...
Cardiff Oncology Onvansertib mCRC Data at ASCO 2026
SAN DIEGO, Calif., April 21, 2026 Cardiff Oncology, Inc. announced it will present updated Phase 2 data for its...
Texas Biomed Advances AI Tools to Transform Drug Testing
SAN ANTONIO, Texas, April 20, 2026 Texas Biomedical Research Institute (Texas Biomed), in collaboration with the Southwest National Primate...
Aligos-Amoytop $445M HBV Licensing Deal Expands Access
SOUTH SAN FRANCISCO, Calif., April 16, 2026 Aligos Therapeutics has entered into an exclusive licensing agreement with Xiamen Amoytop...
Advertisements
Alkermes Reports Strong Phase 2 Data for Narcolepsy Drug
DUBLIN, April 16, 2026 Alkermes plc has announced new data from its Vibrance-1 Phase 2 clinical study of alixorexton,...
AIM ImmunoTech Advances Ampligen Phase 3 Cancer Trial
OCALA, Fla., April 16, 2026 AIM ImmunoTech Inc. has announced significant progress in its oncology pipeline, entering a pivotal...
Apotex Secures FDA Approval for Generic Infuvite Injection
WESTON, FLORIDA, USA, April 14, 2026 Apotex Corp., in collaboration with Orbicular Pharmaceutical Technologies Pvt. Ltd. and Gland Pharma...
SynOx Phase 3 Study Shows TGCT Treatment Benefit
DUBLIN, IRELAND, April 13, 2026 SynOx Therapeutics has announced positive topline results from its pivotal Phase 3 TANGENT study,...
Telix and Regeneron Partner to Advance Radiopharma Therapies
Melbourne, Australia & Tarrytown, New York | April 13, 2026 Telix Pharmaceuticals and Regeneron Pharmaceuticals have announced a strategic...
Advertisement
